Terminated × Interventional × Classical hematology × Clear all ASTER
Phase 3 Terminated
1,150 enrolled
LIMBER
Phase 1/2 Terminated
22 enrolled 28 charts
GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Phase 1 Terminated
84 enrolled
BMS-986253 in Myelodysplastic Syndromes
Phase 1/2 Terminated
2 enrolled 11 charts
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
Phase 2 Terminated
31 enrolled 18 charts
Intra-patient Dose Escalation Study to Investigate Safety and Feasibility of Vactosertib in Treating Anemic MPN Patients
Phase 2 Terminated
2 enrolled 12 charts
NIRAPK
Phase 4 Terminated
12 enrolled
Newton
Phase 2 Terminated
83 enrolled
Cord Blood Transplant With Dilanubicel for the Treatment of HIV Positive Hematologic Cancers
Phase 2 Terminated
1 enrolled 11 charts
To Determine Safe and Effective Dose of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Participants With Advanced Non-small Cell Lung Cancer
Phase 2 Terminated
26 enrolled 18 charts
T-allo10
Phase 1 Terminated
5 enrolled 18 charts
PLATON
Phase NA Terminated
27 enrolled
IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome
Phase 1/2 Terminated
2 enrolled 14 charts
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20)
Phase 3 Terminated
70 enrolled
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
Phase 1 Terminated
2 enrolled
COVID-19 Testing in Underserved and Vulnerable Populations
Phase NA Terminated
9,120 enrolled 8 charts
WAVe
Phase 2 Terminated
92 enrolled
Busulfan, Etoposide, and Intensity-Modulated Radiation Therapy Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Myeloid Cancer
Phase 1/2 Terminated
25 enrolled 9 charts
Bigeminy
Phase 2 Terminated
6 enrolled
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant
Phase 1/2 Terminated
187 enrolled 8 charts
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study
Phase 1/2 Terminated
187 enrolled 8 charts
MK-7962-012
Phase 2 Terminated
30 enrolled 32 charts
Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen
Phase 2 Terminated
17 enrolled 7 charts
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
Phase 2 Terminated
21 enrolled
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome
Phase 1 Terminated
26 enrolled 21 charts
Study of MGTA-117 in Patients With Adult Acute Myeloid Leukemia (AML) and Myelodysplasia-Excess Blasts (MDS-EB)
Phase 1 Terminated
22 enrolled
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients
Phase 1/2 Terminated
9 enrolled
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Phase 2 Terminated
18 enrolled 18 charts
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Phase 3 Terminated
2,549 enrolled 19 charts
PROVE
Phase 3 Terminated
59 enrolled
PROBLEMA
Phase 2 Terminated
29 enrolled 10 charts
SS1
Phase 1 Terminated
14 enrolled
AOC-MM
Phase 4 Terminated
3 enrolled
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
Phase 2 Terminated
6 enrolled 17 charts
A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia
Phase 2 Terminated
3 enrolled 4 charts
Decitabine, Cytarabine, GCSF for Refractory AML/MDS
Phase 2 Terminated
9 enrolled 7 charts
PAC326
Phase 3 Terminated
311 enrolled 12 charts
A Pediatric Trial Using Tranexamic Acid in Thrombocytopenia
Phase 1/2 Terminated
11 enrolled 15 charts
MIPLATE
Phase NA Terminated
422 enrolled 24 charts
Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients
Phase 3 Terminated
246 enrolled
Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
Phase NA Terminated
20 enrolled 9 charts
Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs
Phase 2 Terminated
60 enrolled
PrE0901
Phase 1/2 Terminated
15 enrolled 5 charts
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Phase 2 Terminated
Pacritinib Versus Best Available Therapy to Treat Myelofibrosis
Phase 3 Terminated
327 enrolled 11 charts
Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Phase 2 Terminated
41 enrolled 13 charts
Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
Phase 2 Terminated
3 enrolled 6 charts
PREVENTER
Phase 4 Terminated
501 enrolled 13 charts
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Phase 1 Terminated
1 enrolled
Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)
Phase 2 Terminated
22 enrolled